|
Emcure Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
25648.06 Cr.
|
P/BV
|
6.23
|
Book Value (Rs.)
|
217.34
|
|
52 Week High/Low (Rs.)
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.64
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.95
|
Div Yield (%)
|
0.22
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
| INCOME | | | | |
| Revenue From Operations [Net] | 7808.27 | 6581.99 | 5931.08 | 5766.20 |
| Other Operating Revenues | 87.73 | 76.26 | 54.74 | 89.18 |
| Total Operating Revenues | 7896.00 | 6658.25 | 5985.81 | 5855.39 |
| | | | | |
| Other Income | 67.26 | 56.99 | 45.91 | 63.47 |
| Total Revenue | 7963.26 | 6715.24 | 6031.72 | 5918.86 |
| | | | | |
| EXPENSES | | | | |
| Cost Of Materials Consumed | 1526.90 | 1333.13 | 1146.59 | 1296.10 |
| Purchase Of Stock-In Trade | 1883.24 | 1332.48 | 1047.25 | 1082.45 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -263.53 | -190.19 | 66.69 | -145.40 |
| Employee Benefit Expenses | 1446.29 | 1292.08 | 1117.33 | 1011.82 |
| Finance Costs | 175.78 | 237.15 | 213.61 | 175.98 |
| Depreciation And Amortisation Expenses | 384.13 | 312.41 | 260.12 | 244.86 |
| Other Expenses | 1828.72 | 1661.03 | 1426.77 | 1280.50 |
| Total Expenses | 6981.53 | 5978.08 | 5278.36 | 4946.31 |
| | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 981.73 | 737.16 | 753.36 | 972.55 |
| | | | | |
| Exceptional Items | -10.38 | -9.93 | -6.15 | 0.00 |
| Profit/Loss Before Tax | 971.35 | 727.23 | 747.22 | 972.55 |
| | | | | |
| Tax Expenses-Continued Operations | | | | |
| Current Tax | 292.16 | 209.64 | 173.30 | 286.05 |
| Deferred Tax | -28.28 | -9.99 | 12.07 | -16.06 |
| Total Tax Expenses | 263.88 | 199.65 | 185.37 | 269.99 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 707.47 | 527.58 | 561.85 | 702.56 |
| | | | | |
| Profit/Loss From Continuing Operations | 707.47 | 527.58 | 561.85 | 702.56 |
| | | | | |
| Profit/Loss For The Period | 707.47 | 527.58 | 561.85 | 702.56 |
| | | | | |
| Minority Interest | -26.14 | -29.39 | -29.83 | -40.36 |
| Consolidated Profit/Loss After MI And Associates | 681.33 | 498.18 | 532.02 | 662.20 |
| | | | | |
| OTHER INFORMATION | | | | |
| | | | | |
| EARNINGS PER SHARE | | | | |
| Basic EPS (Rs.) | 36.43 | 27.54 | 29.42 | 36.62 |
| Diluted EPS (Rs.) | 36.43 | 27.54 | 29.42 | 36.62 |
| | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | |
| Equity Share Dividend | 0.00 | 54.26 | 36.17 | 54.26 |
